SEC
AMAG

Seven Eight Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Seven Eight Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,100
Closed -$212K – 733
2016
Q4 		$212K Buy
+6,100
New +$182K 0.04% 396
2015
Q4 		– Sell
-5,700
Closed -$226K – 735
2015
Q3 		$226K Buy
+5,700
New +$354K 0.2% 172
2015
Q2 		– Sell
-2,000
Closed -$109K – 712
2015
Q1 		$109K Buy
+2,000
New +$95.3K 0.18% 191

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seven Eight Capital's AMAG Position: Q1 2017 in Review

Seven Eight Capital sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 6,100 shares — an estimated $212K sold.

Seven Eight Capital first reported a position in AMAG in Q1 2015 and held it in 3 quarters. The position peaked at $226K in Q3 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Seven Eight Capital reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Seven Eight Capital sold 6,100 AMAG Pharmaceuticals shares in Q1 2017, an estimated $212K.
  • Seven Eight Capital first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Seven Eight Capital's AMAG Pharmaceuticals position peaked at $226K in Q3 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Seven Eight Capital's 13F filing for Q1 2017, filed 15 May 2017.